This is the authors' abstract. We don't add key points for this paper.
biological potential of this peptide demonstrating that Kef-1 may be a relevant nutraceutical treatment for cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Aires et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: